TOPPER JAMES N received a stock award from PHATHOM PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/5/2025ACC: 0000950170-25-082454
Director10% Owner
Since Oct 2019
+28K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
28K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+10.50K
Price / share
—
Trade value
—
% of position
32.7%
6/3/2025
32.10K→42.60K
Total
Net shares
+10.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/3/2025 | A · Award | +10.50K | — | — | 32.7% | 32.10K | 42.60K |
| Total | +10.50K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
17.50K shares
Shares
+17.50K
Strike price
4.95
Held after
17.50K
Exercisable
—
6/3/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock17.50K shares | 6/3/2025 | A · Award | +17.50K | 4.95 | — | 17.50K |
Non-Derivative Holdings (Post-Transaction)4
Common Stock
IndirectShares owned1.00
Common Stock
IndirectShares owned59.40K
Common Stock
IndirectShares owned3.91K
Common Stock
IndirectShares owned5.83M
Total
5.89M indirect5.89M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.00 | Indirect |
| Common Stock | 59.40K | Indirect |
| Common Stock | 3.91K | Indirect |
| Common Stock | 5.83M | Indirect |
| Total | 5.89M | 5.89M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported